首页 > 最新文献

Journal of postgraduate medicine最新文献

英文 中文
Navigating healthcare leadership: Theories, challenges, and practical insights for the future. 导航医疗保健领导:理论,挑战和未来的实践见解。
Pub Date : 2024-10-01 Epub Date: 2024-12-11 DOI: 10.4103/jpgm.jpgm_533_24
P K Singh, S Singh, V Kumari, M Tiwari

Abstract: Effective healthcare leadership is essential to ensure high-quality patient care and foster a supportive work environment for healthcare professionals. This review aims to consolidate existing healthcare leadership literature to provide evidence-based insights that can guide leadership development, improve team performance, and enhance patient care outcomes. A systematic search of academic databases such as PubMed, Scopus, Web of Science, CINAHL, Embase, and Google Scholar was performed using keywords related to healthcare leadership. Studies were selected based on their relevance, peer-reviewed status, and focus on healthcare settings. Thematic analysis was employed to synthesize findings from the selected studies. The review explores various leadership theories, including Great Man, trait, behavioral, transactional, transformational, and contingency theories, highlighting their relevance and application in healthcare. Effective healthcare leaders must possess traits such as vision, emotional intelligence, adaptability, and ethical integrity to navigate the complexities of modern healthcare. The review categorizes different leadership styles, including authoritarian, transformational, transactional, servant, and participative, and discusses their application in specific healthcare contexts. Leaders face challenges such as balancing personal and professional responsibilities, adapting to technological advancements, managing financial constraints, and ensuring regulatory compliance. Healthcare leadership requires a dynamic and adaptable approach that integrates various leadership theories and styles to address the unique challenges of the healthcare environment. This review underscores the importance of leadership development programs and calls for further research to explore the practical implementation of leadership strategies in diverse healthcare settings. The findings provide actionable insights for healthcare leaders to tailor their leadership styles to the specific needs of their teams and organizational contexts, ultimately enhancing patient care and operational efficiency.

摘要:有效的医疗保健领导对于确保高质量的患者护理和为医疗保健专业人员营造支持性的工作环境至关重要。本综述旨在整合现有的医疗保健领导力文献,提供基于证据的见解,以指导领导力发展,提高团队绩效,并提高患者护理结果。使用与医疗保健领导力相关的关键字对PubMed、Scopus、Web of Science、CINAHL、Embase和谷歌Scholar等学术数据库进行了系统搜索。根据研究的相关性、同行评议状态和对医疗保健环境的关注来选择研究。专题分析用于综合所选研究的结果。本文探讨了不同的领导理论,包括伟人理论、特质理论、行为理论、交易理论、转变理论和权变理论,重点介绍了它们在医疗保健中的相关性和应用。有效的医疗保健领导者必须具备远见、情商、适应能力和道德操守等特征,才能驾驭现代医疗保健的复杂性。本文对不同的领导风格进行了分类,包括专制型、转型型、事务型、服务型和参与型,并讨论了它们在特定医疗环境中的应用。领导者面临着平衡个人和职业责任、适应技术进步、管理财务约束和确保法规遵从等挑战。医疗保健领导需要一个动态和适应性强的方法,整合各种领导理论和风格,以解决医疗保健环境的独特挑战。这篇综述强调了领导力发展计划的重要性,并呼吁进一步研究以探索领导力战略在不同医疗保健环境中的实际实施。研究结果为医疗保健领导者提供了可操作的见解,帮助他们根据团队和组织环境的特定需求调整领导风格,最终提高患者护理和运营效率。
{"title":"Navigating healthcare leadership: Theories, challenges, and practical insights for the future.","authors":"P K Singh, S Singh, V Kumari, M Tiwari","doi":"10.4103/jpgm.jpgm_533_24","DOIUrl":"10.4103/jpgm.jpgm_533_24","url":null,"abstract":"<p><strong>Abstract: </strong>Effective healthcare leadership is essential to ensure high-quality patient care and foster a supportive work environment for healthcare professionals. This review aims to consolidate existing healthcare leadership literature to provide evidence-based insights that can guide leadership development, improve team performance, and enhance patient care outcomes. A systematic search of academic databases such as PubMed, Scopus, Web of Science, CINAHL, Embase, and Google Scholar was performed using keywords related to healthcare leadership. Studies were selected based on their relevance, peer-reviewed status, and focus on healthcare settings. Thematic analysis was employed to synthesize findings from the selected studies. The review explores various leadership theories, including Great Man, trait, behavioral, transactional, transformational, and contingency theories, highlighting their relevance and application in healthcare. Effective healthcare leaders must possess traits such as vision, emotional intelligence, adaptability, and ethical integrity to navigate the complexities of modern healthcare. The review categorizes different leadership styles, including authoritarian, transformational, transactional, servant, and participative, and discusses their application in specific healthcare contexts. Leaders face challenges such as balancing personal and professional responsibilities, adapting to technological advancements, managing financial constraints, and ensuring regulatory compliance. Healthcare leadership requires a dynamic and adaptable approach that integrates various leadership theories and styles to address the unique challenges of the healthcare environment. This review underscores the importance of leadership development programs and calls for further research to explore the practical implementation of leadership strategies in diverse healthcare settings. The findings provide actionable insights for healthcare leaders to tailor their leadership styles to the specific needs of their teams and organizational contexts, ultimately enhancing patient care and operational efficiency.</p>","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"232-241"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11722716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin. 一项随机、双盲、安慰剂对照研究,评估α -硫辛酸对加巴喷丁或普瑞巴林糖尿病神经病变患者体内adp和胶原诱导的血小板聚集的抑制作用。
Pub Date : 2024-10-01 Epub Date: 2024-12-06 DOI: 10.4103/jpgm.jpgm_310_24
U Pingali, P Sravanasandya, P Mekala, S Yareeda, K Sireesha, I Khan

Background: Diabetic peripheral neuropathy (DPN) is a chronic microvascular complication in diabetic mellitus patients due to chronic hyperglycemia, resulting in platelet hyperactivity and dyslipidemia. Alpha-lipoic acid (ALA) is a potent antioxidant which has antiplatelet activity and lipid-modulating characteristics and plays a major role in the prevention of disease progression.

Aim: To evaluate the effect of ALA on inhibition of platelet aggregation and lipid profile.

Settings and design: This was a prospective, randomized, double-blind, placebo-controlled study conducted at the Department of Clinical Pharmacology and Therapeutics at a tertiary care hospital.

Materials and methods: We recorded efficacy parameters including changes in inhibition of platelet aggregation, lipid profile, blood sugars, and glycated hemoglobin over 12 weeks of ALA (600 mg once daily orally) supplementation in DPN patients on gabapentin (300 mg twice daily [BD]) or pregabalin (75 mg BD) compared to placebo. We used Student's t-test paired and unpaired for within-group and between-group comparisons, respectively.

Results: A total of 52 study participants (males = 22, females = 30) with a mean age 55.63 ± 7.5 years were randomized to receive either ALA or placebo. Between-group analysis at 12 weeks showed that ALA significantly inhibited both collagen-induced platelet aggregation (from 32.61 ± 8.00 to 24.88 ± 5.30; P < 0.001) and adenosine diphosphate-induced platelet aggregation (from 34.00 ± 6.97 to 25.96 ± 6.45; P < 0.001) compared to placebo. Significant reduction in total cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, and triglycerides was found in the ALA group at 12 weeks compared to baseline. No serious adverse events were reported.

Conclusion: ALA, an antioxidant, demonstrated a protective effect against DPN by the virtue of its inhibitory effect on platelet aggregation and lipid-modulating effects and was found to have good safety.

背景:糖尿病周围神经病变(Diabetic peripheral neuropathy, DPN)是糖尿病患者因慢性高血糖引起的一种慢性微血管并发症,可导致血小板过度活跃和血脂异常。α -硫辛酸(ALA)是一种有效的抗氧化剂,具有抗血小板活性和脂质调节特性,在预防疾病进展中起重要作用。目的:探讨ALA对血小板聚集和血脂的抑制作用。背景和设计:这是一项前瞻性、随机、双盲、安慰剂对照的研究,在一家三级医院的临床药理学和治疗学部门进行。材料和方法:与安慰剂相比,我们记录了DPN患者服用加巴喷丁(300 mg每日两次[BD])或普瑞巴林(75 mg BD)补充ALA (600 mg每日一次口服)12周后对血小板聚集、血脂、血糖和糖化血红蛋白的抑制变化。我们分别对组内和组间比较使用配对和不配对的学生t检验。结果:共有52名研究参与者(男性22人,女性30人),平均年龄55.63±7.5岁,随机分为ALA组和安慰剂组。12周组间分析显示,ALA显著抑制胶原诱导的血小板聚集(从32.61±8.00降至24.88±5.30;P < 0.001)和二磷酸腺苷诱导的血小板聚集(从34.00±6.97降至25.96±6.45;P < 0.001)。与基线相比,ALA组在12周时总胆固醇、低密度脂蛋白胆固醇、极低密度脂蛋白胆固醇和甘油三酯显著降低。无严重不良事件报告。结论:ALA是一种抗氧化剂,具有抑制血小板聚集和调节血脂的作用,对DPN具有保护作用,具有良好的安全性。
{"title":"A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin.","authors":"U Pingali, P Sravanasandya, P Mekala, S Yareeda, K Sireesha, I Khan","doi":"10.4103/jpgm.jpgm_310_24","DOIUrl":"10.4103/jpgm.jpgm_310_24","url":null,"abstract":"<p><strong>Background: </strong>Diabetic peripheral neuropathy (DPN) is a chronic microvascular complication in diabetic mellitus patients due to chronic hyperglycemia, resulting in platelet hyperactivity and dyslipidemia. Alpha-lipoic acid (ALA) is a potent antioxidant which has antiplatelet activity and lipid-modulating characteristics and plays a major role in the prevention of disease progression.</p><p><strong>Aim: </strong>To evaluate the effect of ALA on inhibition of platelet aggregation and lipid profile.</p><p><strong>Settings and design: </strong>This was a prospective, randomized, double-blind, placebo-controlled study conducted at the Department of Clinical Pharmacology and Therapeutics at a tertiary care hospital.</p><p><strong>Materials and methods: </strong>We recorded efficacy parameters including changes in inhibition of platelet aggregation, lipid profile, blood sugars, and glycated hemoglobin over 12 weeks of ALA (600 mg once daily orally) supplementation in DPN patients on gabapentin (300 mg twice daily [BD]) or pregabalin (75 mg BD) compared to placebo. We used Student's t-test paired and unpaired for within-group and between-group comparisons, respectively.</p><p><strong>Results: </strong>A total of 52 study participants (males = 22, females = 30) with a mean age 55.63 ± 7.5 years were randomized to receive either ALA or placebo. Between-group analysis at 12 weeks showed that ALA significantly inhibited both collagen-induced platelet aggregation (from 32.61 ± 8.00 to 24.88 ± 5.30; P < 0.001) and adenosine diphosphate-induced platelet aggregation (from 34.00 ± 6.97 to 25.96 ± 6.45; P < 0.001) compared to placebo. Significant reduction in total cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol, and triglycerides was found in the ALA group at 12 weeks compared to baseline. No serious adverse events were reported.</p><p><strong>Conclusion: </strong>ALA, an antioxidant, demonstrated a protective effect against DPN by the virtue of its inhibitory effect on platelet aggregation and lipid-modulating effects and was found to have good safety.</p>","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"191-197"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11722717/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142788158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revealing inducible clindamycin resistance in methicillin-resistant S aureus : A vital diagnostic imperative for effective treatment. 揭示耐甲氧西林金黄色葡萄球菌诱导克林霉素耐药性:有效治疗的重要诊断必要。
Pub Date : 2024-10-01 Epub Date: 2024-11-29 DOI: 10.4103/jpgm.jpgm_271_24
N S Bawankar, G N Agrawal, S S Zodpey

Introduction: The World Health Organization added methicillin-resistant S aureus (MRSA) to the list of "priority pathogens," given its capacity to cause life-threatening infections. Clindamycin is a preferred treatment for non-complicated S aureus-induced skin and soft tissue infections. Its good tissue penetration and oral absorption make it suitable for outpatient therapy. However, the emergence of inducible and constitutive (MLS B ) resistance led to clinical challenges, primarily due to the potential oversight of inducible resistance in routine antimicrobial sensitivity testing.

Materials and methods: This cross-sectional study was conducted at a tertiary care hospital during 2020-2022. A total of 158 MRSA isolates from various clinical specimens were analyzed. The Kirby-Bauer disk diffusion method using cefoxitin disk and D-test were used to identify MRSA and detect inducible clindamycin resistance (ICR), respectively.

Results: Among the 158 MRSA isolates, 34.17% showed constitutive clindamycin resistance (MLS B c), while 22.15% displayed ICR (MLS B i). In addition, 10.13% of isolates demonstrated the MS phenotype, clindamycin, and erythromycin susceptibility, with 53 (33.54%) isolates susceptible to both antibiotics. The relative risk of clindamycin treatment failure was 7.66 times higher if the D-test was not used.

Conclusion: To prevent clindamycin treatment failures, the D-test must be implemented to detect ICR in MRSA isolate. Neglecting simple and cost-effective tests may lead to inaccurate susceptibility reporting, jeopardizing treatment success.

导论:世界卫生组织将耐甲氧西林金黄色葡萄球菌(MRSA)列入“优先病原体”名单,因为它具有引起危及生命的感染的能力。克林霉素是治疗非复杂金黄色葡萄球菌引起的皮肤和软组织感染的首选药物。其良好的组织渗透和口腔吸收使其适合门诊治疗。然而,诱导型和本构型(MLSB)耐药的出现给临床带来了挑战,主要是由于常规抗菌药物敏感性测试中对诱导型耐药的潜在疏忽。材料和方法:本横断面研究于2020-2022年在一家三级保健医院进行。对不同临床标本中分离的158株MRSA进行了分析。采用头孢西丁纸片Kirby-Bauer纸片扩散法鉴定MRSA,采用d检验检测诱导克林霉素耐药(ICR)。结果:158株MRSA中,34.17%的菌株表现为构成性克林霉素耐药(MLSBc), 22.15%的菌株表现为ICR (MLSBi)。10.13%的分离株对克林霉素和红霉素均敏感,53株(33.54%)对两种抗生素均敏感。如果不使用d检验,克林霉素治疗失败的相对风险高出7.66倍。结论:为防止克林霉素治疗失败,必须采用d检验方法检测MRSA分离物的ICR。忽视简单和具有成本效益的检测可能导致不准确的易感性报告,危及治疗成功。
{"title":"Revealing inducible clindamycin resistance in methicillin-resistant S aureus : A vital diagnostic imperative for effective treatment.","authors":"N S Bawankar, G N Agrawal, S S Zodpey","doi":"10.4103/jpgm.jpgm_271_24","DOIUrl":"10.4103/jpgm.jpgm_271_24","url":null,"abstract":"<p><strong>Introduction: </strong>The World Health Organization added methicillin-resistant S aureus (MRSA) to the list of \"priority pathogens,\" given its capacity to cause life-threatening infections. Clindamycin is a preferred treatment for non-complicated S aureus-induced skin and soft tissue infections. Its good tissue penetration and oral absorption make it suitable for outpatient therapy. However, the emergence of inducible and constitutive (MLS B ) resistance led to clinical challenges, primarily due to the potential oversight of inducible resistance in routine antimicrobial sensitivity testing.</p><p><strong>Materials and methods: </strong>This cross-sectional study was conducted at a tertiary care hospital during 2020-2022. A total of 158 MRSA isolates from various clinical specimens were analyzed. The Kirby-Bauer disk diffusion method using cefoxitin disk and D-test were used to identify MRSA and detect inducible clindamycin resistance (ICR), respectively.</p><p><strong>Results: </strong>Among the 158 MRSA isolates, 34.17% showed constitutive clindamycin resistance (MLS B c), while 22.15% displayed ICR (MLS B i). In addition, 10.13% of isolates demonstrated the MS phenotype, clindamycin, and erythromycin susceptibility, with 53 (33.54%) isolates susceptible to both antibiotics. The relative risk of clindamycin treatment failure was 7.66 times higher if the D-test was not used.</p><p><strong>Conclusion: </strong>To prevent clindamycin treatment failures, the D-test must be implemented to detect ICR in MRSA isolate. Neglecting simple and cost-effective tests may lead to inaccurate susceptibility reporting, jeopardizing treatment success.</p>","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"223-226"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11722712/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in implementing an Antimicrobial Stewardship Program (ASP) in developing countries. 在发展中国家实施抗菌药物管理计划(ASP)的挑战。
Pub Date : 2024-10-01 Epub Date: 2024-07-10 DOI: 10.4103/jpgm.jpgm_228_24
C A Divecha, M S Tullu, S Karande
{"title":"Challenges in implementing an Antimicrobial Stewardship Program (ASP) in developing countries.","authors":"C A Divecha, M S Tullu, S Karande","doi":"10.4103/jpgm.jpgm_228_24","DOIUrl":"10.4103/jpgm.jpgm_228_24","url":null,"abstract":"","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"185-190"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11722715/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141565435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of mortality in sepsis patients using stacked ensemble machine learning algorithm. 使用堆叠集成机器学习算法预测败血症患者的死亡率。
Pub Date : 2024-10-01 Epub Date: 2024-12-06 DOI: 10.4103/jpgm.jpgm_357_24
M Babu, M Sappani, M Joy, V K Chandiraseharan, L Jeyaseelan, T D Sudarsanam

Introduction: Machine learning (ML) has been tried in predicting outcomes following sepsis. This study aims to identify the utility of stacked ensemble algorithm in predicting mortality.

Methods: The study was a cohort of adults admitted to a medical unit of a tertiary care hospital with sepsis. The data were divided into a training data set (70%) and a test data set (30%). Boruta algorithm was used to identify important features. In the first phase of stacked ensemble model, weak learners such as random forest (RF), support vector machine (SVM), elastic net, and gradient boosting machine were trained. The SVM was used in phase 2 as meta learner to combine the results of all weak learners. All models were validated using test data.

Results: In our cohort of 1,453 patients, the mortality rate was 27% (95% confidence interval [CI]: 25, 29). The Boruta algorithm identified inotrope use and assisted ventilation as the most important variables, which could predict mortality. The random forest outperforms (area under the curve [AUC]: 97.91%) the other algorithms. The AUCs for the other models are SVM (95.21%), GBM (93.67%), and GLM net (91.42%). However, the stacking of all the above models had an AUC of 92.14%. In the test data set, the accuracy of all methods including the RF method accuracy decreased (92.6 to 85.5%).

Conclusions: The random forest showed high accuracy in train and moderate accuracy in the test data. We suggest more regional open-access intensive care databases that can aid making machine learning a bigger support for healthcare personnel.

机器学习(ML)已被尝试用于预测败血症后的预后。本研究旨在确定堆叠集成算法在预测死亡率中的效用。方法:该研究是一个队列的成年人入院的医疗单位的三级保健医院败血症。数据分为训练数据集(70%)和测试数据集(30%)。采用Boruta算法识别重要特征。在堆叠集成模型的第一阶段,对随机森林(RF)、支持向量机(SVM)、弹性网(elastic net)和梯度增强机(gradient boosting machine)等弱学习器进行训练。第二阶段使用支持向量机作为元学习器,将所有弱学习器的结果结合起来。所有模型均使用试验数据进行验证。结果:在我们的1453例患者队列中,死亡率为27%(95%可信区间[CI]: 25,29)。Boruta算法将肌力使用和辅助通气确定为最重要的变量,可以预测死亡率。随机森林算法优于其他算法(曲线下面积[AUC]: 97.91%)。其他模型的auc分别为SVM(95.21%)、GBM(93.67%)和GLM net(91.42%)。然而,上述所有模型的叠加AUC为92.14%。在测试数据集中,包括RF法在内的所有方法的准确率都有所下降(从92.6下降到85.5%)。结论:随机森林在训练中具有较高的准确率,在测试数据中具有中等的准确率。我们建议更多的区域开放获取重症监护数据库,可以帮助机器学习成为医疗人员的更大支持。
{"title":"Prediction of mortality in sepsis patients using stacked ensemble machine learning algorithm.","authors":"M Babu, M Sappani, M Joy, V K Chandiraseharan, L Jeyaseelan, T D Sudarsanam","doi":"10.4103/jpgm.jpgm_357_24","DOIUrl":"10.4103/jpgm.jpgm_357_24","url":null,"abstract":"<p><strong>Introduction: </strong>Machine learning (ML) has been tried in predicting outcomes following sepsis. This study aims to identify the utility of stacked ensemble algorithm in predicting mortality.</p><p><strong>Methods: </strong>The study was a cohort of adults admitted to a medical unit of a tertiary care hospital with sepsis. The data were divided into a training data set (70%) and a test data set (30%). Boruta algorithm was used to identify important features. In the first phase of stacked ensemble model, weak learners such as random forest (RF), support vector machine (SVM), elastic net, and gradient boosting machine were trained. The SVM was used in phase 2 as meta learner to combine the results of all weak learners. All models were validated using test data.</p><p><strong>Results: </strong>In our cohort of 1,453 patients, the mortality rate was 27% (95% confidence interval [CI]: 25, 29). The Boruta algorithm identified inotrope use and assisted ventilation as the most important variables, which could predict mortality. The random forest outperforms (area under the curve [AUC]: 97.91%) the other algorithms. The AUCs for the other models are SVM (95.21%), GBM (93.67%), and GLM net (91.42%). However, the stacking of all the above models had an AUC of 92.14%. In the test data set, the accuracy of all methods including the RF method accuracy decreased (92.6 to 85.5%).</p><p><strong>Conclusions: </strong>The random forest showed high accuracy in train and moderate accuracy in the test data. We suggest more regional open-access intensive care databases that can aid making machine learning a bigger support for healthcare personnel.</p>","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"209-216"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11722707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142788172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical insights and real-time PCR analysis of the first adeno-enterovirus conjunctivitis outbreak in India: A comprehensive cross-sectional study. 印度首次爆发腺肠病毒结膜炎的临床观察和实时 PCR 分析:一项全面的横断面研究。
Pub Date : 2024-07-01 Epub Date: 2024-08-07 DOI: 10.4103/jpgm.jpgm_256_24
A Aishwarya, R Agarwal, A Garg, V Jain

Objective: This cross-sectional study aimed to investigate the emergence of adeno-enterovirus conjunctivitis, with a focus on its clinical manifestations, prevalence, and implications within the context of acute epidemic conjunctivitis.

Methods: Real-time PCR analysis was employed to precisely identify the viral strain in conjunctival swab samples. A total of 80 patients were tested, and specific clinical symptoms were assessed.

Results: The study revealed the first documented case in India and the second worldwide of adeno-enterovirus conjunctivitis. The prevalence among the tested patients was significant, with 15% testing positive. Those infected with adeno-enterovirus exhibited shorter illnesses (≤3 days). Notably, clinical symptoms such as subconjunctival hemorrhage, chemosis, swelling, photophobia, and epiphora were significantly linked to this viral variant. Multivariable logistic regression analysis highlighted swelling and photophobia as robust predictors for identifying adeno-enterovirus conjunctivitis cases.

Conclusion: The findings underscore the urgent need to recognize adeno-enterovirus conjunctivitis as a potential threat, capable of causing significant ocular morbidity. Swelling and photophobia emerged as robust predictors for identifying cases, emphasizing the importance of vigilant monitoring and comprehension of this viral variant. Proactive measures are essential to address its clinical implications and mitigate its impact on affected populations. Ongoing research is crucial to unravel the complete spectrum of adeno-enterovirus conjunctivitis and guide effective management strategies.

研究目的这项横断面研究旨在调查腺肠病毒结膜炎的出现,重点是其临床表现、流行率以及对急性流行性结膜炎的影响:方法:采用实时 PCR 分析法精确鉴定结膜拭子样本中的病毒株。共对 80 名患者进行了检测,并对具体临床症状进行了评估:结果:该研究发现了印度首例、全球第二例腺肠病毒结膜炎病例。接受检测的患者中发病率很高,15%呈阳性。腺肠病毒感染者的病程较短(≤3 天)。值得注意的是,结膜下出血、化脓、肿胀、畏光和外窥等临床症状与这种病毒变体有明显联系。多变量逻辑回归分析强调,肿胀和畏光是识别腺肠病毒结膜炎病例的有力预测因素:结论:研究结果表明,我们迫切需要认识到腺肠病毒性结膜炎是一种潜在威胁,可导致严重的眼部疾病。肿胀和畏光是确定病例的有力预测因素,这强调了警惕监测和了解这种病毒变体的重要性。必须采取积极主动的措施来应对其临床影响并减轻其对受影响人群的影响。持续的研究对于揭示腺肠病毒结膜炎的全貌和指导有效的管理策略至关重要。
{"title":"Clinical insights and real-time PCR analysis of the first adeno-enterovirus conjunctivitis outbreak in India: A comprehensive cross-sectional study.","authors":"A Aishwarya, R Agarwal, A Garg, V Jain","doi":"10.4103/jpgm.jpgm_256_24","DOIUrl":"10.4103/jpgm.jpgm_256_24","url":null,"abstract":"<p><strong>Objective: </strong>This cross-sectional study aimed to investigate the emergence of adeno-enterovirus conjunctivitis, with a focus on its clinical manifestations, prevalence, and implications within the context of acute epidemic conjunctivitis.</p><p><strong>Methods: </strong>Real-time PCR analysis was employed to precisely identify the viral strain in conjunctival swab samples. A total of 80 patients were tested, and specific clinical symptoms were assessed.</p><p><strong>Results: </strong>The study revealed the first documented case in India and the second worldwide of adeno-enterovirus conjunctivitis. The prevalence among the tested patients was significant, with 15% testing positive. Those infected with adeno-enterovirus exhibited shorter illnesses (≤3 days). Notably, clinical symptoms such as subconjunctival hemorrhage, chemosis, swelling, photophobia, and epiphora were significantly linked to this viral variant. Multivariable logistic regression analysis highlighted swelling and photophobia as robust predictors for identifying adeno-enterovirus conjunctivitis cases.</p><p><strong>Conclusion: </strong>The findings underscore the urgent need to recognize adeno-enterovirus conjunctivitis as a potential threat, capable of causing significant ocular morbidity. Swelling and photophobia emerged as robust predictors for identifying cases, emphasizing the importance of vigilant monitoring and comprehension of this viral variant. Proactive measures are essential to address its clinical implications and mitigate its impact on affected populations. Ongoing research is crucial to unravel the complete spectrum of adeno-enterovirus conjunctivitis and guide effective management strategies.</p>","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"143-148"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458071/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141899258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuro-Behçet's presentation as cerebral venous thrombosis - A report of two cases and review of the literature. 神经性贝赫切氏症表现为脑静脉血栓--两例病例报告及文献综述。
Pub Date : 2024-07-01 Epub Date: 2024-07-12 DOI: 10.4103/jpgm.jpgm_597_23
M Gupta, V B Rao, S Ramakrishnan, G B Kulkarni

Abstract: Cerebral venous thrombosis (CVT) is a rare stroke with multiple risk factors. One rare risk factor is Behçet's disease (BD). Out of around 3000 cases at our center in the past 10 years, two cases of BD with CVT were seen. Herein, we report on their clinical symptoms, course, and management. Case 1 was a 18-year-old girl with a history of recurrent skin lesions presenting with encephalopathy syndrome due to CVT, requiring decompression. Despite our best efforts, she developed complications and expired due to sepsis. Case 2 was a 22-year-old male with raised intracranial pressure syndrome and a history of recurrent orogenital ulcers. His evaluation showed retinal vasculitis, papilledema, and bilateral lateral rectus palsy. Both had CVT on neuroimaging and had positivity for human leukocyte antigen-B51. Case 2 responded to the anticoagulation and immunomodulation. Risk factor identification is essential in managing CVT, and planned evaluation (clinical or investigations) plays an important role in identifying rare causes that need specific treatment.

摘要:脑静脉血栓(CVT)是一种罕见的中风,有多种风险因素。贝赫切特病(BD)是一种罕见的危险因素。在我们中心过去 10 年的约 3000 例病例中,有两例 BD 合并 CVT。在此,我们将报告他们的临床症状、病程和治疗方法。病例 1 是一名 18 岁的女孩,有反复皮肤损伤病史,因 CVT 而出现脑病综合征,需要减压治疗。尽管我们尽了最大努力,但她还是出现了并发症,最终因败血症去世。病例 2 是一名 22 岁的男性,患有颅内压升高综合征和复发性生殖器溃疡。他的检查结果显示患有视网膜血管炎、乳头水肿和双侧直肌外侧麻痹。两人的神经影像学检查均显示有CVT,人类白细胞抗原-B51阳性。病例 2 对抗凝剂和免疫调节有反应。在处理 CVT 时,识别风险因素至关重要,而有计划的评估(临床或检查)在识别需要特殊治疗的罕见病因方面发挥着重要作用。
{"title":"Neuro-Behçet's presentation as cerebral venous thrombosis - A report of two cases and review of the literature.","authors":"M Gupta, V B Rao, S Ramakrishnan, G B Kulkarni","doi":"10.4103/jpgm.jpgm_597_23","DOIUrl":"10.4103/jpgm.jpgm_597_23","url":null,"abstract":"<p><strong>Abstract: </strong>Cerebral venous thrombosis (CVT) is a rare stroke with multiple risk factors. One rare risk factor is Behçet's disease (BD). Out of around 3000 cases at our center in the past 10 years, two cases of BD with CVT were seen. Herein, we report on their clinical symptoms, course, and management. Case 1 was a 18-year-old girl with a history of recurrent skin lesions presenting with encephalopathy syndrome due to CVT, requiring decompression. Despite our best efforts, she developed complications and expired due to sepsis. Case 2 was a 22-year-old male with raised intracranial pressure syndrome and a history of recurrent orogenital ulcers. His evaluation showed retinal vasculitis, papilledema, and bilateral lateral rectus palsy. Both had CVT on neuroimaging and had positivity for human leukocyte antigen-B51. Case 2 responded to the anticoagulation and immunomodulation. Risk factor identification is essential in managing CVT, and planned evaluation (clinical or investigations) plays an important role in identifying rare causes that need specific treatment.</p>","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"162-165"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458080/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new editorial team takes over…. 新的编辑团队上任....
Pub Date : 2024-07-01 Epub Date: 2024-08-06 DOI: 10.4103/jpgm.jpgm_353_24
M S Tullu
{"title":"A new editorial team takes over….","authors":"M S Tullu","doi":"10.4103/jpgm.jpgm_353_24","DOIUrl":"10.4103/jpgm.jpgm_353_24","url":null,"abstract":"","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"127-128"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458072/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141895113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the antiplatelet effect of generic ticagrelor 90 mg (ticaspan ® ) alone and in combination with aspirin 75 mg as compared to ticagrelor (innovator): An in vitro study. 与替卡格雷(创新药)相比,评估非专利药替卡格雷 90 毫克(ticaspan®)单独使用和与阿司匹林 75 毫克联合使用的抗血小板作用:体外研究。
Pub Date : 2024-07-01 Epub Date: 2023-12-07 DOI: 10.4103/jpgm.jpgm_346_23
S Kamat, S Jalgaonkar, P Marathe, S Karekar, D Uchil, S Revankar

Objective: To evaluate an in vitro antiplatelet effect of generic ticagrelor 90 mg (ticaspan) alone and in combination with aspirin 75 mg as compared to the innovator formulation of ticagrelor alone and in combination with aspirin among healthy Indian volunteers.

Methods: 18 volunteers were enrolled and platelet viability was tested using lactate dehydrogenase (LDH) assay in six of 18 volunteers. In 12 volunteers, maximum platelet aggregation (MPA) and percentage inhibition of platelet aggregation (PI) were assessed using a platelet aggregometer in six study groups.

Results: There was no significant increase in LDH levels when platelets were incubated with an innovator or generic drug alone and in combination with aspirin as compared to the dimethyl sulfoxide [DMSO] group. All five study groups showed a significant reduction in the MPA values compared to the DMSO group ( P < 0.01). The extent of decrease in MPA observed with the generic drug was not significantly different from the innovator drug ( P = 0.325). Similarly, the MPA observed with the two combination groups did not differ from each other ( P = 1.000), but it was significantly different from the MPA observed with aspirin ( P = 0.039, each). The PI of platelet aggregation was significantly more in four study groups [generic drug alone; innovator alone; generic drug + aspirin; and innovator drug + aspirin] ( P < 0.01) as compared to the aspirin group.

Conclusion: The generic ticagrelor and its combination with aspirin demonstrated an antiplatelet effect equivalent to the innovator drug and its combination with aspirin.

目的方法:招募 18 名志愿者,使用乳酸脱氢酶(LDH)测定法检测 18 名志愿者中 6 名志愿者的血小板活力。在 12 名志愿者中,使用血小板聚集仪对六个研究组的血小板聚集最大值(MPA)和血小板聚集抑制百分比(PI)进行了评估:结果:与二甲基亚砜组相比,当血小板与创新药或仿制药单独或与阿司匹林联合培养时,LDH 水平没有明显增加。与二甲基亚砜组相比,所有五个研究组的 MPA 值均显著降低(P < 0.01)。非专利药与创新药的 MPA 下降幅度无明显差异(P = 0.325)。同样,两组联合用药观察到的 MPA 也没有差异(P = 1.000),但与阿司匹林观察到的 MPA 有显著差异(P = 0.039,各组)。与阿司匹林组相比,四个研究组[单独使用普通药物组;单独使用创新药物组;普通药物+阿司匹林组;创新药物+阿司匹林组]的血小板聚集PI明显更高(P<0.01):结论:非专利药替卡格雷及其与阿司匹林联用的抗血小板效果与创新药及其与阿司匹林联用的效果相当。
{"title":"Evaluation of the antiplatelet effect of generic ticagrelor 90 mg (ticaspan ® ) alone and in combination with aspirin 75 mg as compared to ticagrelor (innovator): An in vitro study.","authors":"S Kamat, S Jalgaonkar, P Marathe, S Karekar, D Uchil, S Revankar","doi":"10.4103/jpgm.jpgm_346_23","DOIUrl":"10.4103/jpgm.jpgm_346_23","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate an in vitro antiplatelet effect of generic ticagrelor 90 mg (ticaspan) alone and in combination with aspirin 75 mg as compared to the innovator formulation of ticagrelor alone and in combination with aspirin among healthy Indian volunteers.</p><p><strong>Methods: </strong>18 volunteers were enrolled and platelet viability was tested using lactate dehydrogenase (LDH) assay in six of 18 volunteers. In 12 volunteers, maximum platelet aggregation (MPA) and percentage inhibition of platelet aggregation (PI) were assessed using a platelet aggregometer in six study groups.</p><p><strong>Results: </strong>There was no significant increase in LDH levels when platelets were incubated with an innovator or generic drug alone and in combination with aspirin as compared to the dimethyl sulfoxide [DMSO] group. All five study groups showed a significant reduction in the MPA values compared to the DMSO group ( P < 0.01). The extent of decrease in MPA observed with the generic drug was not significantly different from the innovator drug ( P = 0.325). Similarly, the MPA observed with the two combination groups did not differ from each other ( P = 1.000), but it was significantly different from the MPA observed with aspirin ( P = 0.039, each). The PI of platelet aggregation was significantly more in four study groups [generic drug alone; innovator alone; generic drug + aspirin; and innovator drug + aspirin] ( P < 0.01) as compared to the aspirin group.</p><p><strong>Conclusion: </strong>The generic ticagrelor and its combination with aspirin demonstrated an antiplatelet effect equivalent to the innovator drug and its combination with aspirin.</p>","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"129-134"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458081/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138815554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of C-MAC ® conventional blade, D-Blade ™ , and Macintosh laryngoscopes for endotracheal intubation in patients with simulated immobilization using manual in-line stabilization: A randomized trial. 比较 C-MAC® 传统刀片、D-Blade™ 和 Macintosh 喉镜在使用人工在线稳定进行模拟固定的患者中的气管插管效果:随机试验
Pub Date : 2024-07-01 Epub Date: 2024-08-14 DOI: 10.4103/jpgm.jpgm_238_24
M Dabas, M Gupta, S Mohanan, P Kaushik, R Lall

Background: A difficult airway is anticipated with cervical spine injuries (CSIs) as immobilization techniques such as manual in-line stabilization (MILS) are used, which distort the oro-pharyngeal-laryngeal axis. Video laryngoscopes (VLs) make difficult airway management easy, as they do not require axis alignment. The present study aimed to compare the total time taken by Macintosh laryngoscope (ML), conventional blade, and D-blade ™ of C-MAC ® VL in simulated CSI scenarios using MILS.

Methods: Ninety patients were randomly allocated into three groups: Group M (ML), Group C (conventional blade of C-MAC ® ), and Group D (D-blade ™ of C-MAC ® ) with MILS applied before intubation. Primary outcome was the total time taken for successful intubation, while secondary outcomes were to assess Cormack-Lehane (CL) grade, number of attempts, hemodynamic response, and associated complications.

Results: Total time for intubation in Group C was 23.40 ± 7.06 sec compared to 35.27 ± 6.53 and 47.27 ± 2.53 sec in groups D and M, respectively ( P < 0.001). CL-grade I was observed in 15/30 (50%) in Group M, 25/30 (83.3%) in Group C, and 29/30 (96.7%) in Group D. Group M reported 7/30 (23.3%) failed intubations, while none were observed in other groups. Hemodynamic parameters were significantly higher at 3 and 5 min in Group M. Postoperative sore throat was recorded in 12/30 (40%) in Group M compared to 3/30 (10%) in groups C and D each ( P value 0.037).

Conclusion: C-MAC ® VL requires less time for intubation, provides better glottic view, and has higher success, with better attenuation of hemodynamic response and fewer complications compared to ML.

背景:颈椎损伤(CSI)患者预计会出现困难气道,因为使用固定技术(如手动直线稳定术(MILS))会扭曲口-咽-喉轴线。视频喉镜(VL)无需对准轴线,因此可以轻松处理困难气道。本研究旨在使用 MILS 模拟 CSI 场景,比较 Macintosh 喉镜 (ML)、传统刀片和 C-MAC® VL 的 D-blade™ 所耗费的总时间:方法:将 90 名患者随机分为三组:插管前应用 MILS 的 M 组(ML)、C 组(C-MAC® 传统刀片)和 D 组(C-MAC® D-blade™)。主要结果是成功插管所需的总时间,次要结果是评估 Cormack-Lehane(CL)等级、尝试次数、血液动力学反应和相关并发症:C 组插管总时间为 23.40 ± 7.06 秒,而 D 组和 M 组分别为 35.27 ± 6.53 秒和 47.27 ± 2.53 秒(P < 0.001)。M 组中有 15/30 例(50%)、C 组中有 25/30 例(83.3%)和 D 组中有 29/30 例(96.7%)观察到 CL I 级。M 组有 7/30 例(23.3%)插管失败,而其他组均未发现插管失败。M 组有 12/30 人(40%)出现术后咽喉痛,而 C 组和 D 组分别有 3/30 人(10%)出现术后咽喉痛(P 值 0.037):结论:与 ML 相比,C-MAC® VL 所需的插管时间更短,能提供更好的声门视野,成功率更高,对血流动力学反应的衰减更好,并发症更少。
{"title":"Comparison of C-MAC ® conventional blade, D-Blade ™ , and Macintosh laryngoscopes for endotracheal intubation in patients with simulated immobilization using manual in-line stabilization: A randomized trial.","authors":"M Dabas, M Gupta, S Mohanan, P Kaushik, R Lall","doi":"10.4103/jpgm.jpgm_238_24","DOIUrl":"10.4103/jpgm.jpgm_238_24","url":null,"abstract":"<p><strong>Background: </strong>A difficult airway is anticipated with cervical spine injuries (CSIs) as immobilization techniques such as manual in-line stabilization (MILS) are used, which distort the oro-pharyngeal-laryngeal axis. Video laryngoscopes (VLs) make difficult airway management easy, as they do not require axis alignment. The present study aimed to compare the total time taken by Macintosh laryngoscope (ML), conventional blade, and D-blade ™ of C-MAC ® VL in simulated CSI scenarios using MILS.</p><p><strong>Methods: </strong>Ninety patients were randomly allocated into three groups: Group M (ML), Group C (conventional blade of C-MAC ® ), and Group D (D-blade ™ of C-MAC ® ) with MILS applied before intubation. Primary outcome was the total time taken for successful intubation, while secondary outcomes were to assess Cormack-Lehane (CL) grade, number of attempts, hemodynamic response, and associated complications.</p><p><strong>Results: </strong>Total time for intubation in Group C was 23.40 ± 7.06 sec compared to 35.27 ± 6.53 and 47.27 ± 2.53 sec in groups D and M, respectively ( P < 0.001). CL-grade I was observed in 15/30 (50%) in Group M, 25/30 (83.3%) in Group C, and 29/30 (96.7%) in Group D. Group M reported 7/30 (23.3%) failed intubations, while none were observed in other groups. Hemodynamic parameters were significantly higher at 3 and 5 min in Group M. Postoperative sore throat was recorded in 12/30 (40%) in Group M compared to 3/30 (10%) in groups C and D each ( P value 0.037).</p><p><strong>Conclusion: </strong>C-MAC ® VL requires less time for intubation, provides better glottic view, and has higher success, with better attenuation of hemodynamic response and fewer complications compared to ML.</p>","PeriodicalId":94105,"journal":{"name":"Journal of postgraduate medicine","volume":" ","pages":"149-153"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458076/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141977577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of postgraduate medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1